Product image of Cyclopentolate Hydrochloride Minims Bausch & Lomb Uk (Cyclopentolate Hydrochloride Bp) supplied by GNH India

Cyclopentolate Hydrochloride Minims Bausch & Lomb Uk

Active Ingredient:
Cyclopentolate Hydrochloride Bp
Origin:
EU

Cyclopentolate Hydrochloride Minims Bausch & Lomb Uk (Cyclopentolate Hydrochloride Bp)

Cyclopentolate Hydrochloride Minims by Bausch & Lomb UK is an ophthalmic solution used to dilate the pupils. This medication is commonly prescribed for eye examinations and certain eye conditions. It is designed for ocular use and is manufactured in the EU.

Manufacturer / TM Owner

Bausch & Lomb Uk Ltd.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Cyclopentolate Hydrochloride is primarily used to dilate the pupils, a process known as mydriasis. This can be helpful during eye examinations to allow the eye care professional to view the internal structures of the eye more clearly. Additionally, it may be used to treat certain eye conditions that require pupil dilation. Cyclopentolate Hydrochloride is often referred to as a cycloplegic agent, which means it temporarily paralyzes the ability of the eye to focus, or accommodate.

Side Effects

  • When applied to the eye, Cyclopentolate Hydrochloride typically causes pupil dilation within about 25 to 30 minutes. This effect can last for several hours. Some users may experience temporary blurred vision, sensitivity to light, or a mild burning sensation upon application. These effects are usually short-lived and resolve as the medication wears off.

Precautions & Warnings

  • Cyclopentolate Hydrochloride should be used with caution in individuals with certain eye conditions, such as narrow-angle glaucoma. It is important to follow the instructions provided by your healthcare professional when using this medication. Avoid touching the tip of the dropper to any surface to prevent contamination. Store the solution at room temperature and keep it out of reach of children.

Avoid Interactions

  • Cyclopentolate Hydrochloride may interact with other medications, particularly those that also affect the eyes. It is important to inform your healthcare professional about all the medications you are taking before using this solution. Additionally, alcohol and certain other substances may exacerbate the effects of Cyclopentolate Hydrochloride, so it is advisable to avoid them while using this medication.

Frequently Asked Questions

Cyclopentolate Hydrochloride is used to dilate the pupils, which can be helpful during eye examinations and for treating certain eye conditions.

Cyclopentolate Hydrochloride typically causes pupil dilation within about 25 to 30 minutes after application.

Common side effects may include temporary blurred vision, sensitivity to light, and a mild burning sensation upon application.

It is important to consult your healthcare professional before using Cyclopentolate Hydrochloride with other eye medications to avoid potential interactions.

Cyclopentolate Hydrochloride should be stored at room temperature and kept out of reach of children.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Cyclopentolate Hydrochloride Bp

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT